Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)

Chronic Low Back Pain Clinical Trial

Official title:

A Randomized, Double-blind, Multicenter, Parallel Designed Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) in Patients With Chronic Low Back Pain

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02289170
• Other study ID #: OCH-S100-2014
• Secondary ID: HI11C2135
• Status: Recruiting
• Phase: N/A
• First received: October 14, 2014
• Last updated: November 9, 2014
• Start date: September 2014
• Est. completion date: September 2015

Study information

• Verified date: November 2014
• Source: DongGuk University
• Contact: Eun Jung Kim, Ph.D.
• Phone: 82-31-710-3751
• Email: hanijjung[@]naver.com
• Is FDA regulated: No
• Health authority: South Korea: Institutional Review BoardKorea: Ministry for Health and Welfare
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to verify the efficacy and safety of heating and cooling combination therapeutic device (OCH-S100) for patients with chronic low back pain (LBP).

Description:

The investigators targeted the patients with chronic LBP. After treatment in 2 groups - real heating and cooling combination treatment and sham heating and cooling combination treatment - the investigators will compare the effects of pain relief and improvement in disability and range of motion of lumbar region. So the investigators will confirm the efficacy of heating and cooling combination therapy, and further the best treatment method. In addition, the investigators are going to evaluate the safety of abnormal reaction during the treatment.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 80
• Est. completion date: September 2015
• Est. primary completion date: September 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 75 Years

Eligibility

Inclusion Criteria:

1. At least 20 years of age, but below 75 years of age

2. Low back pain in the last 3 months or more

3. Low back pain rated over 40 mm on a 100 mm Visual Analog Scale (VAS)

4. Those who are reliable and willing to cooperate in this test, and obey the restrictions for the treatment period.

5. An understanding of the objectives, methods and efficacy of the clinical trial, and willingness in completing the consent form.

Exclusion Criteria:

1. Trauma to or surgery on the lumbar region within 6 months prior to enrollment

2. Low back pain accompanied by sciatica

3. Systematic disease, and severe dysfunction due to the medical illness (e.g. cancer, infection, etc.)

4. A history of medication, oriental medical treatment, physiotherapy for treating low back pain within the last 4 weeks

5. Neurological disease, such as topical or whole body hypoesthesia in temperature sensation (e.g. stroke, peripheral neuropathy, etc.)

6. Hypersensitivity in heating and cooling stimulation

7. Pregnant and lactating women

8. Participate in the other clinical trials within the last 3 months or after enroll this trial

9. When researchers evaluate that it is not appropriate to participate in this clinical test

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Back Pain
• Chronic Low Back Pain
• Low Back Pain

Intervention

Device:
• Heating and cooling combination therapy
The treatment was applied 10 times for 4 weeks. Most painful 2 points in 8 acupuncture points(both side of Bladder meridian23 (BL23), BL24, BL25, BL26) were used for all the patients assigned to this group.
• Sham heating and cooling therapy
The treatment was applied 10 times for 4 weeks. The sham heating and cooling combination therapy was applied on the 2 of 8 same acupuncture points as in the treatment group.

Locations

Country	Name	City	State
Korea, Republic of	Donnguk University Oriental Medical Hospital	Seongnam	Gyeonggi-do

Sponsors (2)

Lead Sponsor	Collaborator
Eun Jung Kim	Ministry of Health & Welfare, Korea

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline in 100mm Pain Visual Analogue Scale (VAS)	The patient is asked to indicate their perceived pain intensity along a 100 mm horizontal line, where '0' represents 'no pain' and '100', 'unbearable pain'	at baseline and 4 4 weeks later from baseline	No
Secondary	Change from baseline in 100mm Pain Visual Analogue Scale (VAS)	The patient is asked to indicate their perceived pain intensity along a 100 mm horizontal line, where '0' represents 'no pain' and '100', 'unbearable pain'	estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment	No
Secondary	Change from baseline in Korean Oswestry disability index (KODI)	KODI is checked by the patients. KODI is a questionnaire to measure the back-related disability. KODI consists of combination of physical and social restriction through 9 questions covering different dimensions of daily living.	at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment	No
Secondary	Change from baseline in Korean Roland Morris Disability Questionnaire (KRMDQ)	KRMDQ is checked by the patients. KRMDQ is a questionnaire to measure the back-related disability. KRMDQ consists of 24 questions answered yes or no.	at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment	No
Secondary	Change from baseline in Traditional Medicine Back pain Questionnaire (TMBQ)	TMBQ is checked by the patients. TMBQ is a questionnaire to measure the back-related disability in aspect of oriental medicine.	at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment	No
Secondary	Change from baseline in Modified schöber test	Modified schöber test measures the flexion range of motion of lumbar spine. First, investigator marks the point at patients' lumbosacral junction. Then also marks the points at upper 10cm and lower 5cm of the former point in standing position. After marking the 3 points, patients bend anteriorly as best he or she can. Then, investigator measures the length of the latter 2 points.	at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment	No
Secondary	Change from baseline in Finger-to-floor distance	Finger-to-floor distance measures the flexion range of motion of lumbar spine. Patients stand on the box which height is 20cm. Then, patients bend anteriorly in extension of knee and upper limb. Investigator measures the length from floor to 3rd finger.	at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment	No
Secondary	Change from baseline in Finger-to-thigh distraction	Finger-to-thigh distraction measures the lateral bending range of motion of lumbar spine. Patients stand on the box which height is 20cm. Then, patients bend laterally in extension of knee and upper limb. Investigator measures the length from floor to 3rd finger.	at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment	No
Secondary	Adverse Events	Any unpredicted symptoms were checked at each follow up visit and if any, the symptom, time of occurrence, and length of duration were recorded and reported.	estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment	Yes